Thursday, January 19, 2017 12:41:44 PM
1) TPS was "created to take PAWS public";
2) The $200M contract with NHS was totally legit;
3) P4D would generate $200M in WC business;
4) PPO business would take PXYN to the next level;
5) PXYN was in negotiations to purchase several pharmacies years ago;
6) New products would take PXYN to the next level;
7) TPS was an ideal partner;
8) P4D was an ideal partner;
9) Ed Kurtz would take PXYN to the next level;
10) Greg Sundem would take PXYN to the next level;
11) Insurance companies were NOT going to stop paying insane amounts of money for compounding medications;
12) PXYN is a viable company;
13) PXYN will never trade below .03.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM